Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing … Read more
Market Cap & Net Worth: Advanced Enzyme Technologies Limited (ADVENZYMES)
Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) has a market capitalization of $362.78 Million (₹31.42 Billion) as of March 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #18459 globally and #875 in its home market, demonstrating a -4.93% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Advanced Enzyme Technologies Limited's stock price ₹280.70 by its total outstanding shares 111926800 (111.93 Million).
Advanced Enzyme Technologies Limited Market Cap History: 2016 to 2026
Advanced Enzyme Technologies Limited's market capitalization history from 2016 to 2026. Data shows growth from $488.44 Million to $362.78 Million (2.35% CAGR).
Index Memberships
Advanced Enzyme Technologies Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$68.11 Billion | 0.14% | #174 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$1.32 Trillion | 0.01% | #616 of 750 |
Weight: Advanced Enzyme Technologies Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Advanced Enzyme Technologies Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Advanced Enzyme Technologies Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.06x
Advanced Enzyme Technologies Limited's market cap is 0.06 times its annual revenue
0.59x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.30x
Advanced Enzyme Technologies Limited's market cap is 0.30 times its annual earnings
710.94x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $488.44 Million | $2.93 Billion | $758.49 Million | 0.17x | 0.64x |
| 2017 | $342.16 Million | $3.30 Billion | $906.49 Million | 0.10x | 0.38x |
| 2018 | $218.46 Million | $3.88 Billion | $900.55 Million | 0.06x | 0.24x |
| 2019 | $205.38 Million | $4.18 Billion | $1.11 Billion | 0.05x | 0.18x |
| 2020 | $416.89 Million | $4.42 Billion | $1.29 Billion | 0.09x | 0.32x |
| 2021 | $407.09 Million | $5.00 Billion | $1.46 Billion | 0.08x | 0.28x |
| 2022 | $351.85 Million | $5.29 Billion | $1.20 Billion | 0.07x | 0.29x |
| 2023 | $478.61 Million | $5.41 Billion | $1.06 Billion | 0.09x | 0.45x |
| 2024 | $450.21 Million | $6.23 Billion | $1.33 Billion | 0.07x | 0.34x |
| 2025 | $390.63 Million | $6.37 Billion | $1.31 Billion | 0.06x | 0.30x |
Competitor Companies of ADVENZYMES by Market Capitalization
Companies near Advanced Enzyme Technologies Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Advanced Enzyme Technologies Limited by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #71 globally with a market cap of $210.18 Billion USD.
- L'Air Liquide S.A (PINK:AIQUF): Ranked #182 globally with a market cap of $107.70 Billion USD.
- Air Liquide SA (PA:AI): Ranked #200 globally with a market cap of $99.38 Billion USD ( €96.82 Billion EUR).
- Ecolab Inc (NYSE:ECL): Ranked #266 globally with a market cap of $77.81 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #71 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $494.05 |
| #182 | L'Air Liquide S.A | PINK:AIQUF | $107.70 Billion | $187.03 |
| #200 | Air Liquide SA | PA:AI | $99.38 Billion | €172.22 |
| #266 | Ecolab Inc | NYSE:ECL | $77.81 Billion | $272.59 |
Advanced Enzyme Technologies Limited Historical Marketcap From 2016 to 2026
Between 2016 and today, Advanced Enzyme Technologies Limited's market cap moved from $488.44 Million to $ 362.78 Million, with a yearly change of 2.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹362.78 Million | -7.13% |
| 2025 | ₹390.63 Million | -13.23% |
| 2024 | ₹450.21 Million | -5.93% |
| 2023 | ₹478.61 Million | +36.03% |
| 2022 | ₹351.85 Million | -13.57% |
| 2021 | ₹407.09 Million | -2.35% |
| 2020 | ₹416.89 Million | +102.98% |
| 2019 | ₹205.38 Million | -5.99% |
| 2018 | ₹218.46 Million | -36.15% |
| 2017 | ₹342.16 Million | -29.95% |
| 2016 | ₹488.44 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Advanced Enzyme Technologies Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $362.78 Million USD |
| MoneyControl | $362.78 Million USD |
| MarketWatch | $362.78 Million USD |
| marketcap.company | $362.78 Million USD |
| Reuters | $362.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.